⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Inotiv, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Inotiv, Inc.
↗West Lafayette, Indiana, USA
Inotiv, Inc. is a leading contract research organization (CRO) that provides nonclinical and analytical drug discovery and development services, as well as research models and related products. The company supports pharmaceutical, biotechnology, chemical, and medical device industries through its two primary segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).
The company offers a comprehensive suite of services, including disease pharmacology, safety assessment, regulated bioanalysis, and specialized research models. Inotiv has expanded its capabilities through various acquisitions to provide end-to-end support from early discovery through IND-enabling development and clinical support.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$507M
Founded:1974
Ownership:public
Status:operating
STOCK
Exchange:NASDAQ
Ticker:NOTV
Market Cap:$0.00045B
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (CRO)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy, RNA, Peptides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Envigo
Key Partnerships:VUGENE (AI/ML drug discovery), LifeNet Health, Synexa Life Sciences
COMPETITION
Position:Leader
Competitors:Charles River Laboratories, Labcorp (Covance), WuXi AppTec
LEADERSHIP
Key Executives:
Brian Bond - Vice President, Drug Discovery & Translational Sciences
LINKS
Website:inotiv.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Inotiv, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.